Boston Scientific (MEX:BSX) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:BSX Boston Scientific Corp MEX:BSX
83 GF Score
Price MXN780.00
GF Value MXN1,851.88
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific FFO per Share?

FFO per Share only applies to REITs.

MEX:BSX
83GF Score
Boston Scientific Corp MEX:BSX
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN780.00 is trading 57.9% below its estimated GF Value™ of MXN1,851.88. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • FFO per Share:
  • GF Value™: MXN1,851.88 vs. price of MXN780.00 (57.9% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
83GF Score

Get the complete analysis for MEX:BSX

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN780.00
Price
MXN1,851.88
GF Value